COVID-19 therapeutics I: Studies on the inhalation use of MAS receptor agonists in acute lung injury caused by COVID-19 (STAMINA) - GMP production of test substance
- Funded by Federal Ministry of Research, Technology and Space (BMFTR)
- Total publications:0 publications
Grant number: 16LW0013K
Grant search
Key facts
Disease
COVID-19Start & end year
20212023Known Financial Commitments (USD)
$448,960Funder
Federal Ministry of Research, Technology and Space (BMFTR)Research Location
GermanyLead Research Institution
Explicat Pharma GmbHResearch Priority Alignment
N/A
Research Category
Therapeutics research, development and implementationResearch Subcategory
Therapeutics logistics and supply chains and distribution strategiesSpecial Interest Tags
N/AStudy Type
Non-ClinicalClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicable